Select the Abstracts by Number

Click    to view the poster

51   "Resistance Factors" in Highly Exposed Persistently Seronegative (HEPS) Women Married to HIV-Infected Men in Chiang Mai, Thailand.

52   Genetic, Virological and Immunological Characterization of a Cohort of Long-Term Monogamous HIV Discordant Couples.

53   HIV-1-Specific Cellular Responses in HIV-1 Discordant Couples.

54   PET Imaging of the Immune Response to HIV.

55   Evaluation of Immune Activation in HIV-Infected and - Uninfected African Individuals by Single-Cell Analysis of Cytokine Production.

56   Reduced Activation and Apoptosis of Peripheral CD3+ / CD4+ T Cells Persists After Viral Rebound in AIDS Patients Treated with Mycophenolate Mofetil (MMF).

57   Survival of Transfused Donor White Cells in HIV-Infected Recipients.

58   CD4+ T Lymphocyte Activation and Shift from Naive to Effector/Memory Phenotype After HTLV-I Infection and HTLV-I Associated Myelopathy.

59   Human Anti-HIV-1 Monoclonal Antibodies That Completely Prevent SHIV Infection of Rhesus Monkeys Have Potent, Synergistic ADCC Activity.

60   Use of Transgenic Mice for the Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity against Primary HIV-1 Strains.

61   Additive Effects Characterize the Interaction of Most Antibodies Involved in

62   A Human Single-Chain Antibody to gp41 of Human Immunodeficiency Virus Type 1 (HIV-1).

63   Evolution of Plasma Levels of Soluble Interleukin-2 (sIL2-R) and Tumor Necrosis Factor Type II (sTNFII-R) Receptors Is Correlated with Immunologic or Virologic Responses of Patients Treated by Protease Inhibitor- Containing Regimen.

64   Actinomycin D Enhances HIV-1 Replication via an Interleukin-9 Dependent Mechanism.

65   Interleukin-12 (IL-12) Augmentation of T-Cell Proliferation of HIV+ PBMC Is Mediated via IL-12 Receptor Upregulation.

66   Effect of Recombinant Human Soluble Tumor Necrosis Factor Receptor (TNFR, Etanercept) on Interleukin-6 (IL- 6), TNF-α , and Markers of Immune Activation in HIV- Infected Subjects Receiving Interleukin-2 (IL-2).

67   SDF-1 Anti-HIV-1 Fusogenic Activity Is Mediated by Complexing with Heparan Sulfate Proteoglycans.

68   CCR5 Expression, CC- Chemokine Production and Viral Isolation in HIV-Infected Individuals Receiving HAART or HAART + IL-2.

69   Deregulation of the Expression of the Fractalkine/ Fractalkine Receptor Complex in HIV-Infected Patients.

70   Regulation of Cytokines and Chemokines by HIV, Tat, and gp120 in Astrocytes.

71   HIV and SIV gp160/120 Envelope Glycoproteins Induce Upregulation of B7-1 and B7-2 on Antigen-Presenting Cells.

72  HIV-1 gp120 Enhances Expression of CD40 and Co- Stimulatory Molecules on Dendritic Cells, Priming Them To Stimulate T-Cell Lymphoproliferation.

73   Programmed Cell Death Regulation by HIV-1 Envelope Glycoprotein gp120 and the Chemokine SDF-1α in Human B Lymphocytes.

74   Recombinant HIV-1 gp120 Induces Distinct Types of Delayed Hypersensitivity in Persons With or Without Pre- Existing Immunologic Memory.

75   Role of Proinflammatory Mediators and CD11a-Ligand Interactions in HIV-1 Infected Macrophage Transmigration across an Activated HEC-1 Cell Monolayer.

76   T Lymphocytes in the Cervix of Normal Women Show High Levels of Activation Markers and Increased Levels of CCR5 Receptor Expression in Women Taking the Combined Oral Contraceptive.

77   R5 But Not X4 HIV Strains Kill Primary CD4+ T Cells through the Fas Signaling Pathway.

78   Characterisation of the CD4 Th1 and CD8 Responses against Hepatitis C Virus and HIV in Peripheral Blood of HCV-HIV Coinfected Patients.

79   Extrahepatic Manifestation of Hepatitis C in Patients Coinfected with HIV.